Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018 - KSWO, Lawton, OK- Wichita Falls, TX: News, Weather, Sports. ABC, 24/7, Telemundo -

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, June 26, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

http://www.reportlinker.com/p02185203/Molecular-Diagnostics-Market-by-Application-Infectious-Disease-Oncology-Genetics-Microbiology-Technology-PCR-INAAT-DNA-Sequencing-End-User-Hospital-Laboratories-Product-Instruments-Reagent-Service-Software---Global-Forecasts-to-2018.html

Molecular diagnostics (MDx) has emerged as one of the largest and fastest growing segments in the In vitro Diagnostic (IVD) industry. In the span of few years, molecular diagnostics has prospered from a non-existent market to a significant market. PCR tests such as the one from Roche for CT/NG and other tests such as HIV qualitative and HIV quantitative (viral load) are the key factors driving the expansion of the molecular diagnostics market. The private reference laboratories developed tests for infectious diseases and cancer mutations due to the rising incidences and the non-availability of FDA approved assays. The market began to expand due to the existence of different diagnostic kits for genetic diseases and the blood screening for various infectious diseases. The demand for molecular testing increased and the FDA approved molecular diagnostic tests for determining genetic variation responses against cancer drugs. As a result, molecular diagnostic testing is growing at a rapid rate due to the rising adoption of rapid and quick diagnosis.

The reagents product segment accounted for the largest share of the total molecular diagnostics market in 2013 and will continue to grow in the next five years to retain its leading position. The high growth in this segment is attributed to the growing demand for molecular assays. Moreover, the rising incidences of infectious diseases such as HBV, HIV, CT/NG, and MRSA have also contributed to the largest share of the reagents market. The hospitals end user segment accounted for the second largest share in 2013. This segment can monitor various physiological parameters of a patient in order to have an overview of the patients' health and status. Due to the tremendous increase in the number of infectious diseases, hospitals are increasing their investments in molecular diagnostic testing.

The PCR technology segment, on the other hand, will be the fastest growing segment in the coming years due to the evolution in technology that helps in diagnosis of various diseases. With the growing incidences and increasing awareness of various diseases this market is set to grow at a faster pace. Under this segment, the INAAT segment is also expected to grow at a higher pace in the forecast period. The microarray technology is also expected to be among the fastest growing in all other segments of the molecular diagnostics market.

In 2013, North America accounted for the largest share and will retain its leading position by 2018. This growth is attributed to the increasing prevalence of lifestyle diseases and spread of various contagious diseases. Asia is the most lucrative region for molecular diagnostics in the next five years, and is poised to grow at a CAGR of 12.2% in the forecast period. The high population base and the improved purchasing power of patients will drive this market. Moreover, the economic crisis in western countries has propelled the companies to focus on the Asian region, thus leading to the economic growth and rise in the investments in this region, which is further driving the market in a positive direction.

The grey area while estimating the market size was the overlapping nature of the applications segment and while segregating them based on the evaluation of endpoints involved. This was later clarified with the help of various experts that participated in the study.
From an insight perspective, this research report focuses on the qualitative data; market size, share, and growth of various segments and sub-segments; competitive landscape; and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It also focuses on the emerging and high-growth segments of the molecular diagnostics market and the initiatives of their respective governments.

The competitive landscape covers the growth strategies adopted by the industry players in the last three years. The company profiles comprises of the basic views on the key players in the molecular diagnostics market and their product portfolios, developments, and strategies adopted to maintain and increase their market share in the near future.

The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 REPORT DESCRIPTION 17
1.3 MARKETS COVERED 19
1.4 STAKEHOLDERS 21
1.5 MARKET SCOPE 21
1.6 RESEARCH METHODOLOGY 22
1.6.1 MARKET SIZE ESTIMATION & DATA TRIANGULATION 23
1.6.2 KEY DATA FROM SECONDARY SOURCES 25
1.6.3 KEY DATA POINTS FROM PRIMARY SOURCES 26
1.6.4 ASSUMPTIONS 27

2 EXECUTIVE SUMMARY 28

3 PREMIUM INSIGHT 32

4 MARKET OVERVIEW 39

4.1 INTRODUCTION 40
4.2 MARKET SEGMENTATION 40
4.3 MARKET DYNAMICS 42
4.3.1 DRIVERS 42
4.3.1.1 Increasing awareness and acceptance of personalized medicine and companion diagnostics 42
4.3.1.2 Development of biomarker identification and advancements in molecular techniques 42
4.3.1.3 Proteomics and genomics technology research to goad the molecular testing market 43
4.3.1.4 Increase in ageing population to spur growth of the molecular diagnostics market 43
4.3.1.5 Reformations in the reimbursement system 44
4.3.2 RESTRAINTS 44
4.3.2.1 Increased costs of molecular diagnostics tools with new and complex platforms demand skilled labor and mandatory training 44
4.3.2.2 Reimbursement issues 45
4.3.2.3 Complex regulatory framework to delay approvals of new molecular diagnostic tests 45
4.3.3 OPPORTUNITIES 45
4.3.3.1 Extending the reach of molecular diagnostics 45
4.3.3.2 Emerging technologies can soon gain importance in molecular diagnostic tests 46
4.3.4 THREATS 46
4.3.4.1 Lack of budget and labor 46
4.3.4.2 Stringent regulatory framework to stifle the growth of MDx market 47
4.4 MARKET SHARE ANALYSIS 47
4.5 MOLECULAR DIAGNOSTIC LABORATORIES AND TESTS 49
4.6 END-USER ANALYSIS 52
4.7 EFFECTS OF OBAMACARE ON THE MOLECULAR DIAGNOSTICS MARKET 54

5 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 57

5.1 INTRODUCTION 58
5.2 INFECTIOUS DISEASES 61
5.2.1 HEPATITIS B VIRUS (HBV) 63
5.2.2 HEPATITIS C VIRUS (HCV) 64
5.2.3 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 64
5.2.4 TUBERCULOSIS (TB) 64
5.2.5 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) 64
5.2.6 HUMAN PAPILLOMAVIRUS (HPV) 65
5.2.7 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) 65
5.2.8 OTHERS 65
5.3 ONCOLOGY 66
5.3.1 PROSTATE CANCER 68
5.3.2 BREAST CANCER 69
5.3.3 COLORECTAL CANCER 69
5.3.4 OTHERS 69
5.4 GENETICS 70
5.5 BLOOD SCREENING 72
5.6 MICROBIOLOGY 73
5.7 OTHERS 75

6 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 76

6.1 INTRODUCTION 77
6.2 POLYMERASE CHAIN REACTION (PCR) 79
6.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 80
6.4 MICROARRAYS 82
6.5 HYBRIDIZATION (IN SITU HYBRIDIZATION AND FLUORESCENCE IN SITU HYBRIDIZATION) 84
6.6 DNA SEQUENCING & NEXT-GENERATION SEQUENCING 86
6.7 OTHERS 88

7 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT TYPE 89

7.1 INTRODUCTION 90
7.2 INSTRUMENTS 91
7.3 REAGENTS 93
7.4 SERVICES & SOFTWARE 94

8 GEOGRAPHIC ANALYSIS 96

8.1 INTRODUCTION 97
8.2 NORTH AMERICA 99
8.2.1 U.S. 103
8.2.2 CANADA 106
8.3 EUROPE 110
8.3.1 U.K. 115
8.3.2 GERMANY 117
8.3.3 FRANCE 121
8.3.4 ITALY 124
8.3.5 SPAIN 127
8.3.6 REST OF EUROPE 130
8.4 ASIA 133
8.4.1 JAPAN 137
8.4.2 INDIA 140
8.4.3 CHINA 144
8.4.4 REST OF ASIA (ROA) 147
8.5 REST OF THE WORLD (ROW) 150
8.5.1 LATIN AMERICA 153
8.5.2 PACIFIC 157
8.5.3 MIDDLE EAST & AFRICA 160

9 COMPETITIVE LANDSCAPE 163

9.1 INTRODUCTION 163
9.2 NEW PRODUCT LAUNCH 164
9.3 MERGERS & ACQUISITIONS 173
9.4 AGREEMENT/PARTNERSHIP/COLLABORATION/
JOINT VENTURES 178
9.5 EXPANSION 189
9.6 OTHER DEVELOPMENTS 191

10 COMPANY PROFILES 203 (Business Overview, Company Snapshot, Product Portfolio, Key Strategy, & Recent Developments)*

10.1 ABBOTT DIAGNOSTICS, INC. 203
10.2 BECKMAN COULTER, INC. 216
10.3 BECTON, DICKINSON & CO. 223
10.4 BIOMÉRIEUX BUSINESS OVERVIEW 236
10.5 CEPHEID, INC. 243
10.6 GEN-PROBE, INC. (HOLOGIC, INC.) 250
10.7 NOVARTIS AG 258
10.8 QIAGEN 263
10.9 ROCHE DIAGNOSTICS 279
10.10 SIEMENS HEALTHCARE 294

*Details on Business Overview, Company Snapshot, Product Portfolio, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 28
TABLE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2011–2018 ($MILLION) 29
TABLE 3 TOTAL NUMBER OF MOLECULAR DIAGNOSTIC LABORATORIES,
BY REGION 2011-2018 50
TABLE 4 TOTAL NUMBER OF MOLECULAR DIAGNOSTIC TESTS, BY REGION
2011-2018, (MILLIONS) 51
TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 53
TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 60
TABLE 7 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF DISEASE, 2011–2018 ($MILLION) 62
TABLE 8 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SIZE,
BY REGION, 2011–2018 ($MILLION) 63
TABLE 9 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TYPE, 2011–2018 ($MILLION) 67
TABLE 10 ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 68
TABLE 11 GENETICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 71
TABLE 12 BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 72
TABLE 13 MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 74
TABLE 14 OTHER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 75
TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 78
TABLE 16 PCR TECHNOLOGY MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 80
TABLE 17 INAAT MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 81
TABLE 18 MICROARRAY TECHNOLOGY MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 83
TABLE 19 HYBRIDIZATION TECHNOLOGY MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 85
TABLE 20 DNA SEQUENCING & NGS MOLECULAR DIAGNOSTICS MARKET SIZE,
BY REGION, 2011–2018 ($MILLION) 87
TABLE 21 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET SIZE,
BY REGION, 2011–2018 ($MILLION) 88
TABLE 22 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 91
TABLE 23 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 92
TABLE 24 MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 93
TABLE 25 MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET SIZE,
BY REGION, 2011–2018 ($MILLION) 94
TABLE 26 MOLECULAR DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY,
2011–2018 ($MILLION) 98
TABLE 27 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY COUNTRY, 2011–2018 ($MILLION) 100
TABLE 28 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 101
TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TECHNOLOGY, 2011–2018 ($MILLION) 102
TABLE 30 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 103
TABLE 31 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 104
TABLE 32 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 105
TABLE 33 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 106
TABLE 34 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 107
TABLE 35 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 108
TABLE 36 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 109
TABLE 37 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2011–2018 ($MILLION) 111
TABLE 38 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 112
TABLE 39 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 113
TABLE 40 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TYPE OF PRODUCT
& SERVICE, 2011–2018 ($MILLION) 114
TABLE 41 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 115
TABLE 42 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 116
TABLE 43 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 117
TABLE 44 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 118
TABLE 45 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 119
TABLE 46 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 120
TABLE 47 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 121
TABLE 48 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 122
TABLE 49 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 123
TABLE 50 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 124
TABLE 51 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 125
TABLE 52 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 126
TABLE 53 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 127
TABLE 54 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 128
TABLE 55 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 129
TABLE 56 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 130
TABLE 57 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TECHNOLOGY, 2011–2018 ($MILLION) 131
TABLE 58 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 132
TABLE 59 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 134
TABLE 60 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 135
TABLE 61 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 136
TABLE 62 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 137
TABLE 63 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 138
TABLE 64 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 139
TABLE 65 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT
& SERVICE TYPE, 2011–2018 ($MILLION) 140
TABLE 66 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 141
TABLE 67 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 142
TABLE 68 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 143
TABLE 69 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 144
TABLE 70 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 145
TABLE 71 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 146
TABLE 72 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 147
TABLE 73 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 148
TABLE 74 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICES, 2011–2018 ($MILLION) 149
TABLE 75 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION,
2011–2018 ($MILLION) 150
TABLE 76 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 151
TABLE 77 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 152
TABLE 78 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 153
TABLE 79 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 154
TABLE 80 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TECHNOLOGY, 2011–2018 ($MILLION) 155
TABLE 81 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 156
TABLE 82 PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 157
TABLE 83 PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2011–2018 ($MILLION) 158
TABLE 84 PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 159
TABLE 85 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY APPLICATION, 2011–2018 ($MILLION) 160
TABLE 86 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TECHNOLOGY, 2011–2018 ($MILLION) 161
TABLE 87 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TYPE OF PRODUCT & SERVICE, 2011–2018 ($MILLION) 162
TABLE 88 NEW PRODUCT LAUNCH (2011-2014) 165
TABLE 89 MERGERS & ACQUISITIONS (2011-2014) 173
TABLE 90 AGREEMENT/PARTNERSHIP/COLLABORATION (2011-2014) 178
TABLE 91 EXPANSION (2011-2014) 189
TABLE 92 OTHER DEVELOPMENTS(2011-2014) 191

LIST OF FIGURES

FIGURE 1 MARKET SIZE ESTIMATION AND DATA TRIANGULATION 24
FIGURE 2 FORECAST MODEL 25
FIGURE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2011–2018 ($MILLION) 30
FIGURE 4 GLOBAL MOLECULER DIAGNOSTIC MARKET, 2011-2018 ($MILLION) 32
FIGURE 5 GLOBAL MOLECULAR DIAGNOSTIC MARKET DYNAMICS 33
FIGURE 6 GLOBAL MOLECULAR DIAGNOSTIC MARKET SNAPSHOT,
2013 ($MILLION) 34
FIGURE 7 GLOBAL MOLECULAR DIAGNOSTIC MARKET SHARE ANALYSIS,
BY APPLICATION, 2013 & 2018 35
FIGURE 8 OPPORTUNITY MATRIX, GLOBAL MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2013 36
FIGURE 9 GLOBAL MOLECULAR DIAGNOSTIC MARKET, BY END-USER,
2013 & 2018 ($MILLION) 37
FIGURE 10 GLOBAL MOLECULAR DIAGNOSTIC MARKET SHARE ANALYSIS,
BY PRODUCT 2013 38
FIGURE 11 GLOBAL MOLECULAR DIAGNOSTIC MARKET 41
FIGURE 12 GLOBAL MOLECULAR DIAGNOSTIC MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 48
FIGURE 13 GLOBAL MOLECULAR DIAGNOSTIC MARKET, BY END USER, 2013 ($MILLION) 53
FIGURE 14 OPPORTUNITY MATRIX, GLOBAL MOLECULAR DIAGNOSTIC MARKET,
BY APPLICATION, 2013 59
FIGURE 15 GLOBAL MOLECULAR DIAGNOSTIC MARKET SHARE ANALYSIS,
BY TECHNOLOGY (2013 & 2018) 77
FIGURE 16 GLOBAL MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT,
2018 ($MILLION) 90
FIGURE 17 MOLECULAR DIAGNOSTIC MARKET, GEOGRAPHIC ANALYSIS,
BY APPLICATION 2013 ($MILLION) 97
FIGURE 18 KEY GROWTH STRATEGIES, MOLECULAR DIAGNOSTICS MARKET,
2011–2014 164

To order this report: Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
http://www.reportlinker.com/p02185203/Molecular-Diagnostics-Market-by-Application-Infectious-Disease-Oncology-Genetics-Microbiology-Technology-PCR-INAAT-DNA-Sequencing-End-User-Hospital-Laboratories-Product-Instruments-Reagent-Service-Software---Global-Forecasts-to-2018.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

  • Local NewsLocal NewsMore>>

  • SkyWARN 7 Forecast

    SkyWARN 7 Forecast

    Tuesday, July 29 2014 4:40 AM EDT2014-07-29 08:40:46 GMT
    Clouds With a Few Showers & Storms Today...
    Clouds With a Few Showers & Storms Today...
  • Driver injured in collision

    Driver injured in collision

    Tuesday, July 29 2014 12:08 AM EDT2014-07-29 04:08:42 GMT
     LAWTON, Okla._Two cars collided evening in front of a Lawton hospital after a driver made too wide of a turn.
     LAWTON, Okla._Two cars collided evening in front of a Lawton hospital after a driver made too wide of a turn.
  • Drive-by shooting victim shot in the eye

    Drive-by shooting victim shot in the eye

    Tuesday, July 29 2014 12:04 AM EDT2014-07-29 04:04:17 GMT
     The victim of a drive-by shooting remains hospitalized after he was shot in the eye.
     The victim of a drive-by shooting remains hospitalized after he was shot in the eye.
Powered by WorldNow
KSWO-TV, 1401 SE 60th Street
Lawton, OK 73501

Telephone: (580) 355-7000
Fax: (580) 357-3811
Email: news@kswo.com

All content © Copyright 2000 - 2014 Worldnow and KSWO. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.